United StatesDiclofenac Sodium topical gel 3%, 100 g tube (prescription), NDC 51672-1363-7, Lot # AD92721, Exp. 3/31/2027, manufactured by Taro Pharmaceuticals Inc. and distributed by Taro Pharmaceuticals U.S.A., is being recalled nationwide by Sun Pharmaceutical Industries Inc. It was recalled because testing showed an out-of-specification viscosity result (slightly lower than the limit) for the gel.
What's being recalled
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1363-7
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot # AD92721, Exp Date: 3/31/2027.
The hazard
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)